October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
-
Narrated by:
-
By:
About this listen
Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.
- 01:05 Brand interview
- 03:08 MHT and potential side effects in schizophrenia treatment
- 06:16 Estrogen and psychosis prophylaxis
- 07:44 MHT effectiveness
- 10:15 Clinical implications
- 11:27 Strengths and limitations
- 13:47 The need for further study
- 15:54 Further research
- 17:24 Kalin interview
- 17:47 Brand et al.
- 20:17 Partanen et al.
- 23:54 Moran et al.
- 26:48 Gallucci et al.
- 30:38 Arion et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org